Ida Bengtson did not have only one "big discovery", she improved the way that science detected and understood infectious disease.
Image source: Trachoma Hospital, Current Rock Mechanics and Explosive Research Centre
Despite the marginalization she faced, Ida Bengtson was the first woman hired as a bacteriologist at the Hygienic Laboratory of the United States Public Health Service, later known as the National Institutes of Health (NIH) (Breaking Barriers in Science 2025).
Within the next 20 years, eight to 10 more women were hired into the Hygienic Laboratory as scientists, thanks to Bengtson being a pioneer. By this time, she was a senior bacteriologist, providing conservative and thorough conclusions in her work, resulting in numerous publications (Evans 1953).
Much of Bengtson's research focused on infectious diseases, with a notable specialization in toxins and bacterial diseases. Her research led her to move all over the country as one of the most expert bacteriologists of her time, leading movements during war times and for public health. Specifically, she was moved to Rolla, Missouri, to focus on trachoma research, where she slowed the progression of the disease in over 1,000 people. Later, leading to Rolla being named the "American battle front in the war on trachoma". Her trachoma research laid the foundation for later discoveries; however, her work is seldom mentioned and is overlooked (Science 2018). Her research laid the foundations for investigating poorly understood infectious diseases, connecting laboratory findings with patient outcomes, and apply public health strategies to control disease spread. Because of these skills, they later became necessary in the advancement of understanding and diagnosing rickettsial diseases and for her botulism work.
Testing for rickettsial diseases has led to many diagnostic advances. The Weil-Felix test was an early blood test used to detect rickettsial diseases, specifically typhus. This test was performed by mixing a patient's blood with a specific bacterium and looking for agglutination (clumping). There were many flaws with this test: low sensitivity, poor specificity, and delayed positivity (Newby 1986). Bengtson mentioned that it was unable to detect two different diseases. It is noted that Bengtson contributed to refining the Weil-Felix test, but it is challenging to find credit given to her. Bengtson may not have invented this test, but she did make it usable and turned it into a practical diagnostic tool (Bengtson 1945). Additionally, the complement fixation test was another heavily used method in her research for rickettsial diseases. This is a test that she developed. It is a similar concept used to detect specific antibodies in response to an infectious serum. Bengtson noted that this test was more specific than the Weil-Felix test but required a substantial amount of infectious serum; however, it still produced reliable results (Breaking Barriers in Science 2025).
Bengtson made impressive strides in botulism and food preservation techniques. During her studies of Clostridium botulinum, it was concluded that a new strain, termed type C, existed. This strain was not able to be neutralized by an A or B antisera (blood serum with antibodies). Discovered in chickens and producing an effect called "limberneck", which is a paralytic event caused by ingesting fly larvae (Bengtson 1922). Type C is typically found in veterinary medicine, specifically in fur-producing animals, waterbirds, and wild birds. Because of her findings, many years later, this contributed to the U.S and international units standardizing antitoxins for botulism (Evans 1953).
Relevant to today, C. botulinum is prevalent in infants. She proved that type C was causing infantile paralysis. Her discovery has prevented many deaths among humans and animals. Her pioneering work influenced current research and life-saving medical practices (Office of NIH History and Stetten Museum [date unknown]).
Through her research, she contributed to the development of vaccines, specifically for Typhus. This was prominent during World War II as the disease posed a significant threat to troops. There is minimal published research on her full contribution to vaccine development and how it has affected the broader public health. However, it has been stated that many of her contributions stem from utilizing and redefining tests that diagnose hard-to-identify diseases (MD 2020; Breaking Barriers in Science 2025).
It can be assumed that her research was foundational in advancing public health, particularly disease control, treatment, and intervention standardization, as well as in diagnostic methods. Unfortunately, there are limited sources documenting her direct contributions to public health (e.g., laws or regulations); however,her foundational research, enabled informed public health policies to be developed.
Although not strictly an "advancement in the field", it is important to recognize Bengtson's broader influence from her typhus research. Ida A. Bengtson was awarded the Typhus Medal in 1947 for her significant contributions towards the study of typhus during the Second World War. Transitioning from her earlier work on botulism and trachoma, she became a member of the "typhus unit", where she advanced research in diagnostics, understanding of disease progression, transmission, and surveillance. As discussed in the "Testing Mechanisms" section, Bengtson refined the Weil-Felix test, thereby deepening the understanding of rickettsial diseases. These advancements, alongside her broader research, contributed to supporting public health responses and outbreak management throughout the United States, ultimately leading to her receiving this award (US Tpyhus...[Date Unknown]; Lindenmann 2005).
It is worth noting that Ida A. Bengtson's name does not consistently appear in formal databases recognizing recipients of the Typhus Medal; however, multiple secondary sources support her recognition.